YDES
YD Bio Limited Ordinary Shares NASDAQ Listed Aug 29, 2025$8.11
+3.84%
vs $7.81
Mkt Cap $33.6M
52w Low $1.90
34.1% of range
52w High $20.09
50d MA $3.83
200d MA $6.14
P/E (TTM)
-8.2x
EV/EBITDA
—
P/B
5.1x
Debt/Equity
0.0x
ROE
—
P/FCF
-7.1x
RSI (14)
79.30
ATR (14)
$1.06
Beta
0.22
50d MA
$3.83
200d MA
$6.14
Avg Volume
530.5K
Breeze Holdings Acquisition Corp. operates as a clinical-stage biopharmaceutical company focuses on cancer prevention medical diagnostics and the development of exosome-based therapeutics with the potential to transform the treatment of a diseases with unmet medical need. The company is based in Taipei, Taiwan.
No. 3, Xingnan St. · Taipei, TX 115001 · TW
Data updated apr 24, 2026 11:46am
· Source: financialmodelingprep.com